Rashieda Gluck

Rashieda Gluck is a declared insider of Kane Biotech Inc., with filings sourced from SEDI. Over a trading history stretching from 17 May 2018 to 8 October 2019, the count stands at 6 filings.

Sales make up the whole of the open-market record (5 sales, €7,945). In 2019 alone, the filings show no purchases and 5 sales.

The latest filing, published on 12 October 2019, reports an open-market sale of €878 in Kane Biotech Inc. The median gap between a trade and its publication by SEDI is 4 days. The shorter that gap, the sooner other investors can see what insiders have done. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.